Evidence map›Paper›PMID 22545203›Full record

ArticleJournal of parasitology research2012

Toxoplasma on the brain: understanding host-pathogen interactions in chronic CNS infection.

Sushrut Kamerkar, Paul H Davis

Open access · goldAbstract read
In one paragraph

Article in Journal of parasitology research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 3 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 3 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Adverse pregnancy outcomes in Toxoplasma gondii seropositive Hispanic women.The journal of obstetrics and gynaecology research · 2023
    Article
  7. Article
  8. Inhibition ofFrontiers in cellular and infection microbiology · 2022
    Article
  9. Review
  10. Review
  11. Neurological and Neurobehavioral Disorders Associated withJournal of parasitology research · 2021
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. BioMed research international · 2019
    Review
  18. Novel Toxoplasma gondii inhibitor chemotypes.Parasitology international · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sushrut KamerkarDepartment of Biology, University of Nebraska at Omaha, Omaha, NE 68182, USA.
Paul H Davis
University of Nebraska at Omaha · US

Funding

UNMC Structural Biology CoreP20GM103427 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PAUL L SORGEN · 2012 to 2026
$59.2M
ZINC FINGER-INSPIRED FLUORESCENT CHEMOSENSORSP20RR016469 · NCRR · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI TURPEN, JAMES B · 2001 to 2011
$36.2M
Molecular Dissection of Early Toxoplasma gondii Bradyzoite DifferentiationF32AI077268 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVIS, PAUL H · 2008 to 2010
$112k
NCRR NIH HHS P20 RR016469NIAID NIH HHS F32 AI077268NIGMS NIH HHS P20 GM103427
6 · The paper itself

Abstract

Toxoplasma gondii is a prevalent obligate intracellular parasite which chronically infects more than a third of the world's population. Key to parasite prevalence is its ability to form chronic and nonimmunogenic bradyzoite cysts, which typically form in the brain and muscle cells of infected mammals, including humans. While acute clinical infection typically involves neurological and/or ocular damage, chronic infection has been more recently linked to behavioral changes. Establishment and maintenance of chronic infection involves a balance between the host immunity and parasite evasion of the immune response. Here, we outline the known cellular interplay between Toxoplasma gondii and cells of the central nervous system and review the reported effects of Toxoplasma gondii on behavior and neurological disease. Finally, we review new technologies which will allow us to more fully understand host-pathogen interactions.

Identifiers

PMID22545203
PMCPMC3321570
OpenAlexW2076010384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.